• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Early pulmonary involvement in systemic sclerosis assessed by technetium-99m-DTPA clearance rate.

作者信息

Fanti S, De Fabritiis A, Aloisi D, Dondi M, Marengo M, Compagnone G, Fallani F, Cavalli A, Monetti N

机构信息

Department of Nuclear Medicine, S. Orsola-Malpighi Policlinic Hospital, Bologna, Italy.

出版信息

J Nucl Med. 1994 Dec;35(12):1933-6.

PMID:7989973
Abstract

UNLABELLED

Systemic sclerosis (SS) is frequently associated with interstitial lung disease, but clinical symptoms and radiologic abnormalities may occur late in the course of the disease. This study investigated early pulmonary involvement by assessing the clearance rate of inhaled 99mTc-diethylenetriaminepentaacetic acid (DTPA).

METHODS

Sixteen patients with proved SS, no clinical pulmonary symptoms and normal chest radiogram were prospectively studied. The 99mTc-DTPA clearance rate was calculated as the time to half clearance (T1/2) and compared with values obtained in healthy nonsmokers.

RESULTS

Six patients showed abnormally increased clearance (T1/2 < 53 min). Rapid clearance was not correlated to SS disease duration or to abnormal pulmonary function tests. Five of six patients with abnormally increased clearance underwent high-resolution CT, which in all five demonstrated pathologic findings that were suggestive of early interstitial disease.

CONCLUSION

These findings indicate that in SS asymptomatic patients may frequently present with abnormal 99mTc-DTPA clearance; 99mTc-DTPA lung scintigraphy may allow early detection of subclinical pulmonary involvement in SS.

摘要

相似文献

1
Early pulmonary involvement in systemic sclerosis assessed by technetium-99m-DTPA clearance rate.
J Nucl Med. 1994 Dec;35(12):1933-6.
2
Pulmonary clearance of aerosolized 99mTc-DTPA in sarcoidosis I patients.结节病I型患者中雾化99mTc-DTPA的肺清除情况。
Q J Nucl Med Mol Imaging. 2007 Mar;51(1):82-90. Epub 2007 Jan 15.
3
Lung clearance of 99mTc-DTPA in ankylosing spondylitis.强直性脊柱炎患者99mTc-DTPA的肺清除情况
Hell J Nucl Med. 2009 Jan-Apr;12(1):17-21.
4
Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.
Respir Med. 1989 Sep;83(5):403-14. doi: 10.1016/s0954-6111(89)80072-1.
5
Pulmonary involvement in progressive systemic sclerosis: a multidisciplinary approach.
Respiration. 1987;51(4):296-306. doi: 10.1159/000195217.
6
Clearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis.锝-99m-二乙三胺五乙酸清除率及高分辨率计算机断层扫描结果在特发性肺纤维化患者评估中的应用
BMC Pulm Med. 2006 Feb 16;6:4. doi: 10.1186/1471-2466-6-4.
7
Technetium 99m-diethylene triamine penta-acetic acid aerosol clearance in the evaluation of pulmonary involvement in sickle cell disease.
Eur J Haematol. 2006 Feb;76(2):147-52. doi: 10.1111/j.1600-0609.2005.00581.x.
8
Lung clearance of 99mTc-DTPA in systemic lupus erythematosus.
Braz J Med Biol Res. 2002 Jun;35(6):663-8. doi: 10.1590/s0100-879x2002000600005.
9
Clearance of technetium-99m-labeled DTPA in hyperthyroidism without clinical evidence of lung disease, and relation to pulmonary function.无肺部疾病临床证据的甲状腺功能亢进患者中锝-99m标记的二乙三胺五乙酸(DTPA)的清除及其与肺功能的关系
Ann Nucl Med. 2005 Sep;19(6):523-7. doi: 10.1007/BF02985583.
10
Tc-99m DTPA aerosol lung clearance test in systemic lupus erythematosus.
Gaoxiong Yi Xue Ke Xue Za Zhi. 1995 Jul;11(7):379-82.

引用本文的文献

1
Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept.放射组学在系统性硬皮病相关性间质性肺疾病中的适用性:概念验证。
Eur Radiol. 2021 Apr;31(4):1987-1998. doi: 10.1007/s00330-020-07293-8. Epub 2020 Oct 6.
2
Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.系统性硬化症相关间质性肺疾病的新型影像学方法。
Curr Rheumatol Rep. 2019 Apr 25;21(6):25. doi: 10.1007/s11926-019-0826-9.
3
Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.
系统性硬皮病相关间质性肺病的治疗:现有和新兴疗法的综述。
Ann Am Thorac Soc. 2016 Nov;13(11):2045-2056. doi: 10.1513/AnnalsATS.201606-426FR.
4
Interstitial lung disease in systemic sclerosis.系统性硬化症中的间质性肺疾病
Lung. 2007 Jul-Aug;185(4):211-20. doi: 10.1007/s00408-007-9012-3.
5
The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.成人弥漫性实质性肺疾病的诊断、评估与治疗。引言。
Thorax. 1999 Apr;54 Suppl 1(Suppl 1):S1-14. doi: 10.1136/thx.54.suppl_1.s1.